Gius Kerster
Overview
Explore the profile of Gius Kerster including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
936
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Claireaux M, Elias G, Kerster G, Kuijper L, Duurland M, Paul A, et al.
Sci Adv
. 2025 Feb;
11(8):eado1331.
PMID: 39970201
Improving our understanding of B cell transition to memory B cells (MBCs) and antibody-secreting cells (ASCs) is crucial for clinical monitoring and vaccine strategies. To explore these dynamics, we compared...
2.
Kuijper L, Kreher C, Elias G, Claireaux M, Kerster G, Bos A, et al.
Front Immunol
. 2025 Jan;
15:1505719.
PMID: 39742271
Introduction: Upon infection, T cell-driven B cell responses in GC reactions induce memory B cells and antibody-secreting cells that secrete protective antibodies. How formation of specifically long-lived plasma cells is...
3.
Brinkkemper M, Kerster G, Brouwer P, Tran A, Torres J, Ettema R, et al.
PLoS Pathog
. 2024 Oct;
20(10):e1012558.
PMID: 39361585
An effective human immunodeficiency virus 1 (HIV-1) vaccine will most likely have to elicit broadly neutralizing antibodies (bNAbs) to overcome the sequence diversity of the envelope glycoprotein (Env). So far,...
4.
van der Straten K, Guerra D, Kerster G, Claireaux M, Grobben M, Schriek A, et al.
PLoS Pathog
. 2024 Aug;
20(8):e1012453.
PMID: 39146376
Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by human sera is a strong correlate of protection against symptomatic and severe Coronavirus Disease 2019 (COVID-19). The emergence of antigenically...
5.
Vergouwe M, Biemond J, van der Straten K, van Pul L, Kerster G, Claireaux M, et al.
J Infect Dis
. 2024 Jun;
230(4):e860-e871.
PMID: 38843052
Background: The immunological determinants of delayed viral clearance and intrahost viral evolution that drive the development of new pathogenic virus strains in immunocompromised individuals are unknown. Therefore, we longitudinally studied...
6.
Guerra D, Beaumont T, Radic L, Kerster G, van der Straten K, Yuan M, et al.
iScience
. 2023 Oct;
26(10):108009.
PMID: 37841584
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has remained a medical threat due to the evolution of multiple variants that acquire resistance to vaccines and prior...
7.
Guerra D, Beaumont T, RadiA L, Kerster G, van der Straten K, Yuan M, et al.
bioRxiv
. 2022 Oct;
PMID: 36263063
The worldwide pandemic caused by SARS-CoV-2 has remained a human medical threat due to the continued evolution of multiple variants that acquire resistance to vaccines and prior infection. Therefore, it...
8.
Claireaux M, Caniels T, de Gast M, Han J, Guerra D, Kerster G, et al.
Nat Commun
. 2022 Aug;
13(1):4539.
PMID: 35927266
Delineating the origins and properties of antibodies elicited by SARS-CoV-2 infection and vaccination is critical for understanding their benefits and potential shortcomings. Therefore, we investigate the SARS-CoV-2 spike (S)-reactive B...
9.
Tomris I, Bouwman K, Adolfs Y, Noack D, van der Woude R, Kerster G, et al.
PLoS Pathog
. 2022 Mar;
18(3):e1010340.
PMID: 35255100
SARS-CoV-2 attaches to angiotensin-converting enzyme 2 (ACE2) to gain entry into cells after which the spike protein is cleaved by the transmembrane serine protease 2 (TMPRSS2) to facilitate viral-host membrane...
10.
Brouwer P, Brinkkemper M, Maisonnasse P, Dereuddre-Bosquet N, Grobben M, Claireaux M, et al.
Cell
. 2021 Feb;
184(5):1188-1200.e19.
PMID: 33577765
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is continuing to disrupt personal lives, global healthcare systems, and economies. Hence, there is an urgent need for a vaccine that...